RecruitingPhase 3NCT07654374A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure TherapeuticsCharlotte, NC · Durham, NC · Fayetteville, NC · +71 more sites
RecruitingPhase 3NCT06937086Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b StudySponsor: Eli Lilly and CompanyFayetteville, NC · +36 more sites
RecruitingPhase 3NCT06937099Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or OverweightSponsor: Eli Lilly and CompanyFayetteville, NC · +34 more sites
RecruitingPhase 3NCT07654361Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure TherapeuticsCharlotte, NC · Durham, NC · Fayetteville, NC · +68 more sites